Furthermore, SRC-3delta4, a splicing variant of NCOA3, can bridge EGFR to phosphorylate and activate FAK, which potentiates cancer cell survival, proliferation, migration and invasion [15]. The gene discussed is NCOA3; the disease is cancer.